The blog features coverage of maritime forces,NATO,air defence,combat operations,the Department of Defense,the Intelligence Community,space exploration and nature.
Wednesday, January 28, 2009
Biotech Firm Praised
RBC Capital Markets has an outperform rating on Genentech(DNA).Its price target for the stock is 100 dollars.Lazard Capital Markets says Genentech is best in class,producing lifesaving drugs for double digit earnings.
No comments:
Post a Comment